DTE vs IMA
DTE (DTE) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
DTE currently screens at market cap $0. IMA currently screens at market cap $64.7M.
Not investment advice. Open the DTE and IMA stock pages for the full models.
Not investment advice.